Advertisement
Rowan Walrath, Associate Editor
Phone: 617-356-7419
E-Mail: r_walrath@acs.org
Twitter: @rowanwalrath
Areas of coverage: Biotech, pharmaceuticals, start-ups, venture capital, public markets, reproductive health, behavioral health and neuroscience, artificial intelligence, and genetic medicinesRowan is a life sciences reporter for Chemical & Engineering News, reporting on the business of drug making. Rowan is particularly interested in exploring patient-centric drug development, with an eye toward clinical trial design, diversity, and how business leaders can help patients overcome barriers to health-care access.
Rowan previously spent 3 years as the life sciences reporter for the Boston Business Journal, taking the local angle in her coverage of the biotechnology, pharmaceutical, and medical device industries. Over the years, Rowan has reported for Mother Jones, the Boston Globe, and Boston magazine, among other publications, and has fact-checked for Wired, Eater, HuffPost, and others. Interests outside work include exploring the local arts scene, enjoying live music, hiking (when she's not overcoming her latest injury), and fostering cats. Rowan is originally from the Houston area and has a degree in journalism from Northeastern University.
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
